Mirum Pharmaceuticals, Inc. (MIRM) /
The revenue of Mirum Pharmaceuticals, Inc. over the past 7 years
Chart Mirum Pharmaceuticals, Inc.: revenue, fiscal 2019–2025 Open the chart →Mirum Pharmaceuticals, Inc. reported revenue of $521.31M in fiscal 2025, the latest fiscal year on file. In fiscal 2020 it was $0. Year over year, revenue rose every year. The largest one-year move was in fiscal 2022: up 303%, from $19.14M to $77.06M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $521.31M |
| 2024ended Dec 31, 2024 | $336.89M |
| 2023ended Dec 31, 2023 | $186.37M |
| 2022ended Dec 31, 2022 | $77.06M |
| 2021ended Dec 31, 2021 | $19.14M |
| 2020ended Dec 31, 2020 | $0 |
| 2019ended Dec 31, 2019 | — |
Fiscal years as Mirum Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Mirum Pharmaceuticals, Inc.
- The profitability of Mirum Pharmaceuticals, Inc.
- The cash flow of Mirum Pharmaceuticals, Inc.
- The debt of Mirum Pharmaceuticals, Inc.
- All of Mirum Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- CNOCNO Financial Group, Inc.
- AROCArchrock, Inc.
- BRZEBraze, Inc.
- TENBTENABLE HOLDINGS, INC.
- UNFUNIFIRST CORPORATION
Not investment advice. This page shows what Mirum Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.